|Dosage Form||Capsule, suspension (oral; 20mg, 4mg/ml)|
|Drug Class||Receptor agonists|
|Company||Vanda Pharmaceuticals Inc.|
- Oral suspension is indicated for the treatment of nighttime sleep disturbances in SMS in pediatric patients 3 years to 15 years of age.
- Capsules are indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) in adults and Nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) in patients 16 years of age and older.